Sine Health Gains FDA Clearance for First Smartphone Essential Tremor Monitor
· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

Original GlobeWire Daily editorial illustration — not an event photograph.
Sine Health announced that the U.S. Food and Drug Administration has granted 510(k) clearance for Sine, its smartphone-based essential tremor monitoring system. According to the company's announcement, the application is designed to measure tremors passively using existing smartphone sensors.
How the Technology Operates
- Passive Tracking: The application runs in the background like a step counter during a patient's routine daily activities.
- Objective Clinical Data: It aims to provide clinicians with continuous insights into how tremors change between scheduled clinic visits.
- First of Its Kind: The company reports this is the first FDA-cleared monitoring method for essential tremor utilizing solely a smartphone.
Context and Background
Essential tremor impacts an estimated 7 million individuals in the United States. Jakob Gerstl, MBBS, MPH, founder and CEO of Sine Health, stated that intermittent in-clinic observations often make medication and surgical optimization challenging, particularly as new therapies emerge.
This regulatory milestone marks the company's second FDA clearance since its founding, following a June 2026 clearance for a Parkinson's disease monitoring system utilizing Apple Watches.
Practical Implications and Verification
- Patient Routine: Users do not need additional hardware, as the software utilizes existing smartphone sensors.
- Verification: Interested parties can review the official FDA 510(k) clearance database under identifier K261026 or consult Sine Health's official announcements for further updates.
AI-assisted reporting; source claims are attributed and have not been independently verified.



